ScholarIQanswers from OpenAlex

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells

PaperCitations, authors & open-access status

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells have?

ScholarIQcitation count

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells has 292 citations in the OpenAlex counts ScholarIQ stores.

When was Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells published?

ScholarIQyear

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells has 2015 year in the ScholarIQ index.

What is the open-access status of Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells?

ScholarIQoa status

Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells has bronze oa status in the ScholarIQ index.

What is the DOI of Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells?

ScholarIQdoi

The DOI for Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells is on the source record.

What is the PMID of Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells?

ScholarIQpmid

The PMID for Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells is on the source record.

What is the OpenAlex record for Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells?

ScholarIQopenalex

The OpenAlex for Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial